Canada markets closed

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.49-0.10 (-1.52%)
At close: 04:00PM EST
6.49 0.00 (0.00%)
After hours: 04:31PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close6.59
Bid6.10 x 900
Ask7.50 x 800
Day's Range6.17 - 6.66
52 Week Range5.50 - 41.86
Avg. Volume499,554
Market Cap369.345M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-2.10
Earnings DateMar. 16, 2022 - Mar. 21, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.80
  • GlobeNewswire

    Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that the company will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 12, 2022. Presentation DetailsDate: Wednesday, Jan. 12, 2022Time: 8:15-8:55 a.m. ET A live webcast of the company presentation and Q&A session will be available on the investor secti

  • Business Wire

    SHAREHOLDER ALERT: Robbins LLP Investigates Generation Bio Co. (GBIO) on Behalf of Shareholders

    SAN DIEGO, December 29, 2021--Generation Bio Co. (GBIO) Reports Poor Results for Preclinical Studies for Hemophilia A Program

  • GlobeNewswire

    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO

    NEW YORK, Dec. 19, 2021 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Generation Bio Co. (“Generation” or the “Company”) (NASDAQ: GBIO). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529, ext. 7980. The investigation concerns whether Generation Bio and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the cl